J Hepatol:酒精性肝硬化 预防骨折性命攸关

2018-11-20 吴星 环球医学网

肝硬化的患病率正在不断增加,其是骨质疏松和骨折的风险因素。肝硬化后骨折对生命构成极大的威胁,甚至估计30天死亡率高达10%。但目前对酒精性肝硬化患者髋部骨折的实际风险知之甚少。

肝硬化的患病率正在不断增加,其是骨质疏松和骨折的风险因素。肝硬化后骨折对生命构成极大的威胁,甚至估计30天死亡率高达10%。但目前对酒精性肝硬化患者髋部骨折的实际风险知之甚少。

研究者使用英国和丹麦全国注册的一级和二级医疗机构数据,量化了两个国家队列酒精性肝硬化患者的髋部骨折风险。研究于2018年发表于《J Hepatol》上。

研究者对3706名英国和17779名丹麦酒精性肝硬化患者进行了随访,从总人群中匹配对照,并评估患者组vs对照组的髋部骨折风险比(HR),调整了年龄、性别和合并症。

结果表明,英国和丹麦肝硬化患者5年髋部骨折风险都显着升高。

调整了混杂因素后,英国和丹麦肝硬化患者的髋部骨折发生率分别增加5倍和8.5倍。

酒精性肝硬化和髋部骨折风险之间的相关性与年龄具有显着的相互作用,年龄低于45岁的患者比75岁以上患者的相关性更强。

酒精性肝硬化患者髋部骨折后的30天死亡率,英国和丹麦分别为11.1%和10.0%,调整年龄后的死亡率比分别为2.8和2.0。

因此,与一般人群相比,酒精性肝硬化患者髋部骨折风险和髋部骨折后死亡率显着增加,髋部骨折发生率比无该病的患者高5倍多。髋部骨折的后果也是相当严重,高达11%的酒精性肝硬化患者在髋部骨折后的30天内死亡。

酒精性肝硬化为公共卫生健康带来较大的负担,酒精性肝硬化患者需要预防骨折。

原始出处:
Otete H1, Deleuran T2, Fleming KM3, et al.Hip fracture risk in patients with alcoholic cirrhosis: A population-based study using English and Danish data.J Hepatol. 2018 ;69(3):697-704. doi: 10.1016/j.jhep.2018.04.002.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2026345, encodeId=d6e52026345d7, content=<a href='/topic/show?id=7dbd95485d2' target=_blank style='color:#2F92EE;'>#酒精性肝硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95485, encryptionId=7dbd95485d2, topicName=酒精性肝硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Mar 16 10:00:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673445, encodeId=123c16e344574, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Fri Feb 15 16:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1427261, encodeId=e119142e261b0, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Nov 22 07:00:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046355, encodeId=6bac104635573, content=谢谢!最新的信息读起来就是收获大, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Tue Nov 20 19:00:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353163, encodeId=6f7935316309, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Tue Nov 20 16:40:35 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2026345, encodeId=d6e52026345d7, content=<a href='/topic/show?id=7dbd95485d2' target=_blank style='color:#2F92EE;'>#酒精性肝硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95485, encryptionId=7dbd95485d2, topicName=酒精性肝硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Mar 16 10:00:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673445, encodeId=123c16e344574, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Fri Feb 15 16:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1427261, encodeId=e119142e261b0, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Nov 22 07:00:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046355, encodeId=6bac104635573, content=谢谢!最新的信息读起来就是收获大, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Tue Nov 20 19:00:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353163, encodeId=6f7935316309, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Tue Nov 20 16:40:35 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2026345, encodeId=d6e52026345d7, content=<a href='/topic/show?id=7dbd95485d2' target=_blank style='color:#2F92EE;'>#酒精性肝硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95485, encryptionId=7dbd95485d2, topicName=酒精性肝硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Mar 16 10:00:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673445, encodeId=123c16e344574, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Fri Feb 15 16:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1427261, encodeId=e119142e261b0, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Nov 22 07:00:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046355, encodeId=6bac104635573, content=谢谢!最新的信息读起来就是收获大, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Tue Nov 20 19:00:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353163, encodeId=6f7935316309, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Tue Nov 20 16:40:35 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
    2018-11-22 gwc384
  4. [GetPortalCommentsPageByObjectIdResponse(id=2026345, encodeId=d6e52026345d7, content=<a href='/topic/show?id=7dbd95485d2' target=_blank style='color:#2F92EE;'>#酒精性肝硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95485, encryptionId=7dbd95485d2, topicName=酒精性肝硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Mar 16 10:00:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673445, encodeId=123c16e344574, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Fri Feb 15 16:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1427261, encodeId=e119142e261b0, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Nov 22 07:00:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046355, encodeId=6bac104635573, content=谢谢!最新的信息读起来就是收获大, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Tue Nov 20 19:00:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353163, encodeId=6f7935316309, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Tue Nov 20 16:40:35 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
    2018-11-20 guging

    谢谢!最新的信息读起来就是收获大

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2026345, encodeId=d6e52026345d7, content=<a href='/topic/show?id=7dbd95485d2' target=_blank style='color:#2F92EE;'>#酒精性肝硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95485, encryptionId=7dbd95485d2, topicName=酒精性肝硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Mar 16 10:00:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673445, encodeId=123c16e344574, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Fri Feb 15 16:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1427261, encodeId=e119142e261b0, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Nov 22 07:00:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046355, encodeId=6bac104635573, content=谢谢!最新的信息读起来就是收获大, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Tue Nov 20 19:00:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353163, encodeId=6f7935316309, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Tue Nov 20 16:40:35 CST 2018, time=2018-11-20, status=1, ipAttribution=)]
    2018-11-20 吴教授

    学习了,学习了

    0

相关资讯

MOL METAB :酒精性肝病怎么治?研究发现重要新药线索!

饮酒过多酒精可能会损害肝脏,但调查人员发现可能有助于治疗酒精性肝病的保护性反应措施。 Beth Israel Deaconess医疗中心(BIDMC)的研究人员与宾夕法尼亚大学的同事合作组织的团队也发现,同样的保护措施可能与厌恶酒精有关,因此有助于治疗酒精中毒。

第四届全国脂肪性肝病学术会议纪要

  由中华医学会肝病学分会脂肪肝酒精性肝病学组与中国工程院医药卫生学部联合主办,第三军医大学大坪医院和上海交通大学新华医院共同承办的“第四届全国脂肪性肝病学术会议”于2011年7月21日至24日在重庆举行。大会主席庄辉院士、范建高教授和执行主席陈东风教授,与来自香港、台北、新加坡以及全国20余个省市的500余名代表参会。全会包括1个主题演讲(脂肪肝酒精性肝病学组10周年回顾)、5个继教讲座、20个